Health and Fitness Health and Fitness
Thu, November 1, 2012
[ Thu, Nov 01st 2012 ] - Market Wire
BioSpecifics Technologies Corp. to Host Conferenc .. uarter 2012 Financial Results on November 8, 2012
[ Thu, Nov 01st 2012 ] - Market Wire
Halozyme to Host Third Quarter Financial Results Conference Call
[ Thu, Nov 01st 2012 ] - Market Wire
Medicure Completes Share Consolidation
[ Thu, Nov 01st 2012 ] - Market Wire
ProMetic Presenting Positive New Anti-Fibrotic Da .. Society of Nephrology Annual Meeting in San Diego
[ Thu, Nov 01st 2012 ] - Market Wire
CombiMatrix Corporation Selects Cartagenia BENCHl .. b CNV Platform to Bolster Expanded Lab Operations
[ Thu, Nov 01st 2012 ] - Market Wire
Financial Review on Healthcare Stocks Teva Pharma .. Allergan Inc. -- Drug Manufacturers Focusing on E
[ Thu, Nov 01st 2012 ] - Market Wire
Financial Review on Healthcare Stocks Forest Labo .. Solutions Inc. -- Drug Manufacturers Focusing on
[ Thu, Nov 01st 2012 ] - Market Wire
Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2012
[ Thu, Nov 01st 2012 ] - Market Wire
BioTech Medics, Inc. Signs Letter of Interest Wit .. or $5 Million Cross-Marketing Licensing Agreement
[ Thu, Nov 01st 2012 ] - Market Wire
Hansen Medical Announces Third Quarter 2012 Results Conference Call
[ Thu, Nov 01st 2012 ] - Market Wire
Cornerstone Therapeutics Receives Complete Response Letter From the FDA for Lixivaptan
[ Thu, Nov 01st 2012 ] - Market Wire
Accuray Receives FDA 510(k) Clearance for New Cyb .. Multileaf Collimation with Non-Isocentric Robotic
[ Thu, Nov 01st 2012 ] - Market Wire
Life Technologies Collaborates with USDA to Devel .. p Same-Day, Multi-Strain E. coli Detection System
[ Thu, Nov 01st 2012 ] - Market Wire
30 a.m. ET November 8, 2012 to Discuss Third Quarter 2012 Results
[ Thu, Nov 01st 2012 ] - Market Wire
Digirad Corporation Reports 2012 Third Quarter and Nine-Month Financial Results
[ Thu, Nov 01st 2012 ] - Market Wire
Neovasc Inc. Finalizes US $4.6 Million Agreement .. ts to In-House Manufacture of Xenosure Surgical P
[ Thu, Nov 01st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Hold Third Quarter 2012 .. s Conference Call and Webcast on November 6, 2012
Wed, October 31, 2012
[ Wed, Oct 31st 2012 ] - Market Wire
Watson Announces Global Generics Management Team
[ Wed, Oct 31st 2012 ] - Market Wire
Watson Announces New Name -- Actavis -- for Global Operations
[ Wed, Oct 31st 2012 ] - Market Wire
Watson Completes Actavis Acquisition
[ Wed, Oct 31st 2012 ] - Market Wire
Sanofi and Regeneron Announce Publication of Phas .. rol-Lowering PCSK9 Antibody in the New England Jo
[ Wed, Oct 31st 2012 ] - Market Wire
Arena Pharmaceuticals to Host Corporate Update an .. onference Call and Webcast on Tuesday, November 6
[ Wed, Oct 31st 2012 ] - Market Wire
Corcept Therapeutics Announces Third Quarter Results and Corporate Update
[ Wed, Oct 31st 2012 ] - Market Wire
Neurocrine Biosciences Reports Third Quarter 2012 Results
[ Wed, Oct 31st 2012 ] - Market Wire
Varian Medical Systems Highlights a Comprehensive .. lio for the Non-Invasive Treatment of Lung Cancer
[ Wed, Oct 31st 2012 ] - Market Wire
Masimo to Present at Lazard Capital Markets 9th Annual Healthcare Conference
[ Wed, Oct 31st 2012 ] - Market Wire
MethylGene to Present MGCD265 Data at the 24th EO .. sium on Molecular Targets and Cancer Therapeutics
[ Wed, Oct 31st 2012 ] - Market Wire
Dynavax to Initiate Phase 1 Studies for TLR-9 Agonist for Asthma
[ Wed, Oct 31st 2012 ] - Market Wire
USANA Health Sciences COO, Roy Truett, Named Top COO by ExecRank
[ Wed, Oct 31st 2012 ] - Market Wire
Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call

Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call


Published on 2012-10-31 05:17:52 - Market Wire
  Print publication without navigation


Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call

SEATTLE, WA, Oct. 31, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: [ ONTY ]) today announced that it will conduct a conference call on Wednesday, November 7, 2012 at 4:30 p.m. Eastern Time to discuss its financial results and provide a review of its pipeline of products in development.

To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International).  In addition, the call will be webcast live and can be accessed on the "Events" page of the "News & Events" section of Oncothyreon's website at [ www.oncothyreon.com ].  An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].

SOURCE Oncothyreon Inc.



Contributing Sources